17:18 EST VYNE Therapeutics files $250M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on VYNE:
- VYNE Reports 2023 Fourth Quarter and Year-End Financial Results and Provides Business Update
- VYNE Therapeutics expects cash to fund operations through 2025
- VYNE Therapeutics reports Q4 EPS (20c) vs. ($2.60) last year
- VYNE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- VYNE Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference